Home > Health > Platelet Aggregation Devices Market estimated worth $342.4 Million by 2020

Platelet Aggregation Devices Market estimated worth $342.4 Million by 2020

Added: (Fri May 12 2017)

Pressbox (Press Release) - The report “Platelet Aggregation Devices Market by Product (Systems, Reagents, Consumables, Accessories), Application (Research, Diagnostic, CVD, Orthopedic, Trauma), End User (Hospitals, Diagnostic Laboratories, Academia, Blood Banks) - Global Forecasts to 2020”, The Global Platelet Aggregation Devices Market Is Poised to Reach $342.4 Million by 2020, Growing at a CAGR of 21.0% from 2015 to 2020.

Browse 71 tables and 40 figures spread through 137 pages and in-depth TOC on "Platelet Aggregation Devices Market",
Early buyers will receive 10% customization on reports.

On the basis of products, the global platelet aggregation devices market is classified into three major segments, namely, systems, reagents, and consumables & accessories. On the basis of applications, the global platelet aggregation devices market is classified into research applications and clinical applications.

The clinical applications segment is further classified into three sub segments, namely, cardiovascular, orthopedic, and other clinical applications (includes monitoring of antiplatelet therapy and urology, trauma, and bleeding disorders).

Get The PDF Brochure For This Report@

Factors such as rising incidences of target diseases, rapid growth in the geriatric population across the globe, technological advancements in platelet aggregometers, and increasing number of industry-academia collaborations and clinical studies are fuelling the growth of the global platelet aggregation devices market.

On the other hand, procedural limitations, unfavorable healthcare reforms in the U.S., and dearth of well trained and skilled professionals are some of the key factors hampering the growth of this market.

Ask For Discount@

As of 2015, North America is expected to hold the largest share of the platelet aggregation devices market, followed by Europe. Additionally, North America is expected to grow at the highest CAGR during the forecast period (2015 to 2020). Strong market growth witnessed in the North American platelet aggregation devices market can be attributed to factors such as large patient population for target diseases; strong presence of device manufacturers in the region; growing number of surgical procedures; rising awareness among healthcare professionals (regarding the benefits offered by platelet aggregation testing in disease diagnosis); large number of patients undergoing cardiovascular surgeries; and increasing prevalence of orthopedic, urological, and bleeding disorders.

F. Hoffmann La-Roche Ltd. (Switzerland), Haemonetics Corporation (U.S.), Sysmex Corporation (Japan), Siemens AG (Germany), Accriva Diagnostics (U.S.), Helena Laboratories Corporation (U.S.), Bio/Data Corporation (U.S.), Tem Group (Switzerland), Sentinel CH. S.p.A. (Italy), and Aggredyne, Inc. (U.S.) are the major players in the global platelet aggregation devices market.

About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Rohan
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441

Submitted by:Mr. Rohan
Disclaimer: Pressbox disclaims any inaccuracies in the content contained in these releases. If you would like a release removed please send an email to remove@pressbox.co.uk together with the url of the release.